INSIGHTS ON PHARMACEUTICAL INSPECTION

PHARMACEUTICAL INSPECTION SOLUTIONS

  • Meet FDA guidelines for GMP in tablet and capsule production with a secure, failsafe system. Qualification reports are available.

  • See how modern metal detection improves sensitivity, smart system designs, and tailored inspection technologies to strengthen quality control across food and pharmaceutical production.

  • Discover a flexible, high-performance solution that can inspect up to 350 syringes and vials per minute.

  • Pharmaceutical X-Ray inspection systems have the highest level of contaminant detection with the ability to find a wide range of non-metal and metal contaminants.

  • The pharmaceutical industry continues to lead industries in terms of quality requirements and the value of data. The shift to more automated processes is less about the cost of human capital, but more about the pursuit of quality. The European Medicines Agency (EMA) updated Annex 1, driving for 100% inspection on fused containers and appropriate quality test measures for applications based on level of risk. The United States Pharmacopeia (USP) revamped Chapter 1207 on container closure integrity (CCI) to be prescriptive of deterministic technologies and encourages a deeper understanding of a container’s CCI requirements. The FDA continues to drive a ‘quality culture’ agenda versus a ‘compliance culture’, and the FDA has been explicitly targeting data integrity as a campaign for assuring quality. Every regulatory and guidance body is driving towards more reliable and accurate test methods.